Asthma Control-A Patient Follow up Programme Maintenance and Reliever Therapy in a Single Inhaler

A Patient Follow-up Program to Assess Asthma Control in Patients Using Symbicort® as Maintenance and Relief Therapy in a Single Inhaler (Symbicort® SMART: Budesonide/Formoterol 160/4.5 Mcg, 1 or 2 Inhalations x 2 Times Plus Additional Inhalations as Needed)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00524641

Enrollment

1254

Registered

2007-09-03

Start date

2007-07-31

Completion date

2008-04-30

Last updated

2009-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Asthma, Symbicort, NIS

Brief summary

To investigate the change in patient's asthma symptom control using ACQ scores after 4 to 6 weeks of Symbicort Turbuhaler (budesonide/ formoterol) in SMART approach.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Asthma patients from both sexes, age 18 or older * Have already been on Symbicort SMART treatment * Willing to give written informed consents to participate in the program.

Exclusion criteria

* Patients who are not willing to give written informed consent * Patients in emergency care for asthma at ICUs or COPD patients are excluded from the program.

Countries

Vietnam

Outcome results